{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:49:09Z","timestamp":1768002549976,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.cellsig.2024.111067","type":"journal-article","created":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T08:45:30Z","timestamp":1706345130000},"page":"111067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs"],"prefix":"10.1016","volume":"116","author":[{"given":"Esther Sathya Bama","family":"Benjamin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Vinod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raveen Stephen Stallon","family":"Illangeswaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharathi M.","family":"Rajamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakhi Thalayattu","family":"Vidhyadharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhirup","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnab","family":"Maity","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajith","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"Parasuraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soosai Manickam","family":"Amirtham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aby","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaji R","family":"Velayudhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poonkuzhali","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2024.111067_bb0005","series-title":"Molecular Sciences Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is it Worth the Effort?","author":"Soverini","year":"2021"},{"key":"10.1016\/j.cellsig.2024.111067_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-023-01929-6","article-title":"Genetic separation of chronic myeloid leukemia stem cells from normal hematopoietic stem cells at single-cell resolution","author":"Chen","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.cellsig.2024.111067_bb0015","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2024.111067_bb0020","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","article-title":"Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival","volume":"119","author":"Hamilton","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2024.111067_bb0025","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","article-title":"Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia","volume":"94","author":"Holyoake","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2024.111067_bb0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI43605","article-title":"BCR-ABL kinase is dead; long live the CML stem cell","volume":"121","author":"Perl","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2024.111067_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02427-x","article-title":"A non-cell-autonomous role for Pml in the maintenance of leukemia from the niche","volume":"9","author":"Guarnerio","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2024.111067_bb0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","article-title":"Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia","volume":"21","author":"Zhang","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2024.111067_bb0045","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bcp.2010.04.003","article-title":"The bone marrow microenvironment as a sanctuary for minimal residual disease in CML","volume":"80","author":"Nair","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2024.111067_bb0050","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1007\/s13277-014-2610-9","article-title":"New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia","volume":"35","author":"Shahrabi","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cellsig.2024.111067_bb0055","doi-asserted-by":"crossref","first-page":"12167","DOI":"10.1074\/jbc.RA119.008037","article-title":"Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7\/JAK1\/STAT5 pathway","volume":"294","author":"Zhang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2024.111067_bb0060","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1101\/gad.1588607","article-title":"Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia","volume":"21","author":"Williams","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.cellsig.2024.111067_bb0065","first-page":"73","article-title":"Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option","volume":"142","author":"Dolinska","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2024.111067_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030523","article-title":"Direct generation of immortalized erythroid progenitor cell lines from peripheral blood mononuclear cells","volume":"10","author":"Bagchi","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cellsig.2024.111067_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00106","article-title":"Mesenchymal stem cells support survival and proliferation of primary human acute myeloid leukemia cells through heterogeneous molecular mechanisms","volume":"8","author":"Brenner","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2024.111067_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285106","article-title":"Human fetal cartilage-derived chondrocytes and chondroprogenitors display a greater commitment to chondrogenesis than adult cartilage resident cells","volume":"18","author":"Vinod","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2024.111067_bb0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.celrep.2019.03.009","article-title":"The hematopoietic oxidase NOX2 regulates self-renewal of leukemic stem cells","volume":"27","author":"Adane","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellsig.2024.111067_bb0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41408-018-0053-z","article-title":"The small GTPase RhoU lays downstream of JAK\/STAT signaling and mediates cell migration in multiple myeloma","volume":"8","author":"Canovas Nunes","year":"2018","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.cellsig.2024.111067_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1187066","article-title":"Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo","volume":"14","author":"Rajamani","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2024.111067_bb0100","article-title":"ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia","author":"Lipreri da Silva","year":"2023","journal-title":"Hematol. Transfus. Cell. Ther."},{"key":"10.1016\/j.cellsig.2024.111067_bb0105","article-title":"ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia","author":"Lipreri da Silva","year":"2023","journal-title":"Hematol. Transfus. Cell. Ther."},{"key":"10.1016\/j.cellsig.2024.111067_bb0110","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3390\/molecules26051323","article-title":"Pathogenic roles of S100A8 and S100A9 proteins in acute myeloid and lymphoid leukemia: clinical and therapeutic impacts","volume":"26","author":"Mondet","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.cellsig.2024.111067_bb0115","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1038\/s41388-020-1261-0","article-title":"Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and \u03b21 integrin activation","volume":"39","author":"Floren","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2024.111067_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-023-01751-9","article-title":"New frontiers in immune checkpoint B7-H3 (CD276) research and drug development","volume":"22","author":"Getu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2024.111067_bb0125","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","article-title":"Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt\u2013\u03b2-catenin signaling","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2024.111067_bb0130","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1111\/liv.12797","article-title":"Human bone marrow mesenchymal stem cell-derived hepatocytes express tissue inhibitor of metalloproteinases 4 and follistatin","volume":"35","author":"Xin","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.cellsig.2024.111067_bb0135","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood.V85.4.997.bloodjournal854997","article-title":"Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6\/E7 genes","author":"Roecklein","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2024.111067_bb0140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41419-022-04822-9","article-title":"Mesenchymal stem cells empower T cells in the lymph nodes via MCP-1\/PD-L1 axis","volume":"13","author":"He","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2024.111067_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035685","article-title":"Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis","volume":"7","author":"Boomsma","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2024.111067_bb0150","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.18632\/oncotarget.13664","article-title":"The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63\/PI3K\/Akt\/p21 signaling","volume":"8","author":"Forte","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2024.111067_bb0155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/dna.1994.13.571","article-title":"\u03b2ig-h3: a transforming growth factor-\u03b2-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice","volume":"13","author":"Skonier","year":"1994","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.cellsig.2024.111067_bb0160","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012911","article-title":"Follistatin is a novel therapeutic target and biomarker in <scp>FLT<\/scp> 3\/ <scp>ITD<\/scp> acute myeloid leukemia","volume":"12","author":"He","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cellsig.2024.111067_bb0165","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/imr.12749","article-title":"Cell circuits and niches controlling B cell development","volume":"289","author":"Zehentmeier","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellsig.2024.111067_bb0170","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/leu.2016.34","article-title":"TGF-\u03b1 and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy","volume":"30","author":"Nievergall","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.cellsig.2024.111067_bb0175","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.leukres.2014.02.011","article-title":"Decreased frequency, but normal functional integrity of mesenchymal stromal cells derived from untreated and Imatinib-treated chronic myeloid leukemia patients","volume":"38","author":"Estrada-Gonz\u00e1lez","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.cellsig.2024.111067_bb0180","doi-asserted-by":"crossref","first-page":"11439","DOI":"10.3390\/ijms222111439","article-title":"From primary MSC culture of adipose tissue to immortalized cell line producing cytokines for potential use in regenerative medicine therapy or immunotherapy","volume":"22","author":"Paprocka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2024.111067_bb0185","series-title":"Immortalized Mesenchymal Stem Cells: A Safe Cell Source for Cellular or Cell Membrane-Based Treatment of Glioma","author":"Zhang","year":"2022"},{"key":"10.1016\/j.cellsig.2024.111067_bb0190","doi-asserted-by":"crossref","first-page":"25055","DOI":"10.18632\/aging.203779","article-title":"IGFBP-6\/sonic hedgehog\/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis","volume":"13","author":"Longhitano","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.cellsig.2024.111067_bb0195","article-title":"IGFBP-6 alters mesenchymal stromal cell phenotype driving dasatinib resistance in chronic myeloid leukemia","volume":"13","author":"Cambria","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.cellsig.2024.111067_bb0200","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.stem.2012.01.003","article-title":"Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling","volume":"10","author":"Csaszar","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cellsig.2024.111067_bb0205","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/16078454.2021.1978763","article-title":"Role of matrix metalloproteinase MMP-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP-1) in the clinical progression of pediatric acute lymphoblastic leukemia","volume":"26","author":"Saleh","year":"2021","journal-title":"Hematology"},{"key":"10.1016\/j.cellsig.2024.111067_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002157","article-title":"Nidogen 1-enriched extracellular vesicles facilitate extrahepatic metastasis of liver cancer by activating pulmonary fibroblasts to secrete tumor necrosis factor receptor 1","volume":"7","author":"Mao","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.cellsig.2024.111067_bb0215","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41420-022-01042-0","article-title":"The roles of osteoprotegerin in cancer, far beyond a bone player","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2024.111067_bb0220","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012911","article-title":"Follistatin is a novel therapeutic target and biomarker in <scp>FLT<\/scp> 3\/ <scp>ITD<\/scp> acute myeloid leukemia","volume":"12","author":"He","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cellsig.2024.111067_bb0225","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3324\/haematol.2019.230227","article-title":"Targeting of plasminogen activator inhibitor-1 activity promotes elimination of chronic myeloid leukemia stem cells","volume":"106","author":"Yahata","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.cellsig.2024.111067_bb0230","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ijc.20266","article-title":"Elevated expression of CCL5\/RANTES in adult T-cell leukemia cells: possible transactivation of the CCL5 gene by human T-cell leukemia virus type I tax","volume":"111","author":"Mori","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cellsig.2024.111067_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.554301","article-title":"Approaching inflammation paradoxes\u2014proinflammatory cytokine blockages induce inflammatory regulators","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2024.111067_bb0240","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/s41375-018-0175-0","article-title":"Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML","volume":"32","author":"Br\u00fcck","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.cellsig.2024.111067_bb0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11899-023-00688-6","article-title":"The bone marrow immune microenvironment in CML: treatment responses, treatment-free remission, and therapeutic vulnerabilities","volume":"18","author":"Patterson","year":"2023","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.cellsig.2024.111067_bb0250","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/bjh.16718","article-title":"Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells","volume":"191","author":"Irani","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cellsig.2024.111067_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.643382","article-title":"Combination therapies in chronic myeloid leukemia for potential treatment-free remission: focus on leukemia stem cells and immune modulation","volume":"11","author":"Mu","year":"2021","journal-title":"Front. Oncol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656824000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656824000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:16:33Z","timestamp":1760267793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656824000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":51,"alternative-id":["S0898656824000354"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2024.111067","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2024.111067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111067"}}